Analysis of Potential Genotoxic Impurities in Active Pharmaceutical Ingredients (4) - Analysis of Haloalcohols and Glycidol Part 2 -

Importance of the Topic

The presence of haloalcohols and glycidol in pharmaceutical substances is a critical safety concern due to their genotoxic potential and regulatory limits. Sensitive and reliable methods are required to detect and quantify these impurities at trace levels to ensure product safety and compliance.

Objectives and Study Overview

This study aims to develop and validate a gas chromatography mass spectrometry method for quantitation of 2-chloroethanol, 2-bromoethanol, 2-iodoethanol and glycidol in active pharmaceutical ingredients. The method performance is assessed in terms of sensitivity, linearity and recovery.

Methodology

The analytes were prepared as TMS derivatives via reaction with N,O-bis(trimethylsilyl)trifluoroacetamide at 70 degrees Celsius for thirty minutes. Calibration standards in acetonitrile covered concentrations from 0.025 to 25 micrograms per milliliter, corresponding to 1 to 1000 nanograms per milligram in the API matrix. A recovery test employed a trazodone matrix spiked at 5 nanograms per milligram. Sample cleanup involved extraction with dichloromethane, phase separation, and drying over anhydrous sodium sulfate.

Instrumentation

• Gas chromatograph coupled to a mass spectrometer operated in selected ion monitoring mode
• TMS derivatization module with temperature control
• Shimadzu GC MS system as specified in Application Data Sheet No 41

Main Results and Discussion

• Sensitivity: Limit of quantitation at 0.025 microgram per milliliter (1 nanogram per milligram) with signal to noise ratio above 10.
• Linearity: Calibration curves over the range showed correlation coefficients of at least 0.9998, indicating excellent linear response.
• Recovery: Haloalcohol recoveries ranged from 84 to 101% with repeatability below 4% RSD. Glycidol recovery was lower at 59.7% with 4.3% RSD, suggesting incomplete extraction or derivatization efficiency for this compound.

Benefits and Practical Applications

The validated GC-MS method provides a robust tool for quality control laboratories to monitor genotoxic impurities in pharmaceutical ingredients. High sensitivity and linearity enable compliance with regulatory guidelines and support risk assessment during drug development and release.

Future Trends and Potential Applications

• Optimization of derivatization protocols to improve glycidol recovery
• Implementation of two dimensional gas chromatography for enhanced separation
• Integration with high resolution mass spectrometry for confirmatory analysis
• Automation of sample preparation to increase throughput and reproducibility

Conclusion

The reported GC-MS approach achieves the required sensitivity, linearity and precision for haloalcohols in APIs, while highlighting the need for improved procedures for glycidol analysis. This method supports regulatory compliance and can be further refined with advanced chromatographic and detection technologies.

References

• Frank David, Karine Jacq, Pat Sandra, Andrew Baker and Matthew S Klee Analysis of potential genotoxic impurities in pharmaceuticals by two dimensional gas chromatography with Deans switching and independent column temperature control using a low thermal mass oven module Anal Bioanal Chem 396 1291-1300 2010